Tvardi Therapeutics (TVRD) Change in Acquisitions & Divestments (2016 - 2026)

Tvardi Therapeutics has reported Change in Acquisitions & Divestments for 11 years, with the latest figure at $5.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 9.43% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (down 26.71% YoY) and the FY2025 annual result came in at $21.4 million, down 73.9% from the prior year.
• Change in Acquisitions & Divestments held at $5.0 million in Q1 2026 per TVRD's latest filing, from $5.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $59.0 million in Q1 2024 and troughed at $2.5 million in Q3 2024.
• A 5-year average of $24.4 million and a median of $15.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 448.01% in 2022, then sank 94.6% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $58.2 million in 2022, then plunged by 36.74% to $36.9 million in 2023, then sank by 86.43% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025, then decreased by 0.48% to $5.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $5.0 million, $5.0 million, and $5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.